Three intravitreal injections of ranibizumab were performed with monthly intervals. continued to be steady at 2-calendar year follow-up without angiographical leakage. Intravitreal shots of ranibizumab
Three intravitreal injections of ranibizumab were performed with monthly intervals. continued to be steady at 2-calendar year follow-up without angiographical leakage. Intravitreal shots of ranibizumab